Neogenesis Biotech › News & Insights › Continuous Optimization of the Solid Tumor TIL Testing Workflow
Continuous Optimization of the Solid Tumor TIL Testing Workflow
Continuously improving TIL testing quality to build a more comprehensive tumor immunology analysis.
Tumor-Infiltrating Lymphocytes (TILs) are a cornerstone of tumor immunology research and cell therapy. Because immune cell composition, the tumor microenvironment, and levels of immunosuppression vary significantly between patients, establishing a standardized, high-quality TIL testing workflow is a vital step toward precision medicine.
Axiom Biotech is continuously optimizing its TIL testing workflow by integrating multi-color flow cytometry, AI Cell Report, and immune cell analysis technologies, with the goal of building a more comprehensive and consistent tumor immunology assessment platform.
Ready to start your precision medicine journey?
Contact our experts to learn about cellular intelligence and health management.
More in Clinical Research and Trial Progress
Keep reading on related topics
Ongoing clinical research collaboration with Taipei Veterans General Hospital continues to advance.
Neogenesis Biotech partners with Taipei Veterans General Hospital to advance clinical research by in…
The Vital Role of Companion Diagnostics in Cell Therapy
In recent years, cell therapy has emerged as a key frontier in regenerative medicine. However, not e…